RecruitingNot ApplicableNCT05942885

Hypnosis: a Path to Appeasement


Sponsor

Hospices Civils de Lyon

Enrollment

50 participants

Start Date

Oct 30, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Hypnosis is a technique allowing the patient to focus his mental attention on a thought or a sensation, with the aim of reducing or modulating the intensity of a negative feeling or an ordeal encountered during the course of treatment. This tool can be used when patients are faced with chronic disorders (pain, anxiety, ...) or iatrogenic effects (nausea, asthenia, ...). The patient is referred to hypnosis care by the doctor, psychologist or paramedics who follow him, when they detect a need. Several scientific studies have shown the effectiveness of hypnosis in improving the quality of life of patients with breast cancer and in reducing pain during invasive procedures. On the other hand, in hematology, no research has measured the evolution of anxiety, over time, in patients receiving hypnotherapy.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Patients over 18 years old, fluent in French.
  • Patients starting hypnotherapy for anxiety disorders.
  • Anxiety score on the HADS scale (Hospital Anxiety and Depression Scale) greater than or equal to 8/21
  • Patients with diffuse large cell B-cell lymphoma or follicular lymphoma, whatever the stage of the disease.
  • Diagnosis announcement less than 2 months old

Exclusion Criteria2

  • Persons deprived of their liberty by a judicial or administrative decision
  • Adults subject to a legal protection measure

Interventions

OTHERanxiety questionnaire

Patient undergoing hypnosis session will have their anxiety measured just before the third session of hypnosis and after during a telephonic consultation. The result will be compared to the anxiety level before the first hypnosis session


Locations(1)

Service MB1 - Hôpital Lyon Sud - HCL

Lyon, Pierre-Bénite, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05942885


Related Trials